Oscar Health Stock Rockets 22.9% Amid Q3 Filing and T. Rowe Price Stake

Introduction

Oscar Health Inc (NYS: OSCR) is an American for-profit health insurance company founded in 2012 and headquartered in New York City. Built around a full-stack technology platform, Oscar offers individual, family, and small-group plans, as well as telemedicine services and transparent claims pricing. The company's mission focuses on providing accessible and affordable healthcare through digital engagement and personalized member support.

Corporate Structure and Workforce

Oscar Health is led by Chief Executive Officer Mark Bertolini and Group Chief Financial and Operating Officer Sid Sankaran. As of September 30, 2025, the company serves approximately 2.1 million members across its Individual, Small Group, and Medicare Advantage lines. Oscar employs teams of software engineers, care navigators, and licensed agents in various offices, including New York, Texas, California, and Arizona. The company reports that 44% of members actively use digital channels and maintains dedicated Care Teams to assist each policyholder.

Health Insurance by Scott Graham

Developments and News

• On November 6, 2025, Oscar Health filed its Form 10-Q for the quarter ended September 30, 2025, disclosing year-to-date financial and operational updates.
• On November 14, 2025, T. Rowe Price Investment Management filed an amendment to Schedule 13G/A, reporting beneficial ownership of 8,322,004 shares, representing 3.7% of Class A common stock as of September 30, 2025.
• On November 24, 2025, Oscar’s share price increased by 22.85% to close at $16.56 on the NYSE, with a trading volume of 2,783,895 shares.

Financial and Strategic Analysis

For the twelve months ended September 30, 2025, Oscar Health reported:

• Revenue (ttm): $11.29 billion
• Net loss: $244.1 million (profit margin: –2.16%)
• Diluted EPS: –$0.90
• Total cash and equivalents: $3.04 billion
• Total debt/equity: 72.25%
• Levered free cash flow (ttm): $515.9 million

Valuation multiples from Yahoo Finance indicate a price-to-sales ratio of 0.30 and a price-to-book ratio of 4.18. The beta of 1.88 suggests above-average share volatility. Strategic initiatives include the ongoing rollout of Oscar Primary Care in select states, expansion of the +Oscar health-tech platform for partners, and a partnership established with Cigna in 2020 to serve small businesses.

Market Position and Industry Context

Operating within the U.S. health insurance sector—one of the world’s largest and most regulated markets—Oscar Health competes against established carriers in the Affordable Care Act exchanges and commercial markets. Its technology-driven model emphasizes member trust; on average, 44% of members engage with digital services, and Net Promoter Scores exceed industry benchmarks for virtual care satisfaction. Oscar’s membership of approximately 2.1 million represents about 1 in 13 ACA exchange enrollees, indicating growth from 1.6 million members in 2023.

tl;dr

On November 24, 2025, Oscar Health shares increased by 22.85% to $16.56 following its Q3 2025 earnings filing (Nov 6) and confirmation that T. Rowe Price holds a 3.7% stake (filed Nov 14). Year-to-date revenue is reported at $11.29 billion, with a net loss of $244.1 million. Membership has grown to 2.1 million, supported by digital engagement and expanded care offerings. Future developments focus on technology investments, geographic expansion of Oscar Primary Care, and strengthening partnerships such as Cigna + Oscar.